Allegra Medical Technologies (ASX:AMT) Debt-to-Equity : -0.90 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Allegra Medical Technologies Debt-to-Equity?

Allegra Medical Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$1.45 Mil. Allegra Medical Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil. Allegra Medical Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$-1.61 Mil. Allegra Medical Technologies's debt to equity for the quarter that ended in Dec. 2023 was -0.90.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Allegra Medical Technologies's Debt-to-Equity or its related term are showing as below:

ASX:AMT' s Debt-to-Equity Range Over the Past 10 Years
Min: -2.09 Med: 0.07 Max: 2.22
Current: -0.9

During the past 13 years, the highest Debt-to-Equity Ratio of Allegra Medical Technologies was 2.22. The lowest was -2.09. And the median was 0.07.

ASX:AMT's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.21 vs ASX:AMT: -0.90

Allegra Medical Technologies Debt-to-Equity Historical Data

The historical data trend for Allegra Medical Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allegra Medical Technologies Debt-to-Equity Chart

Allegra Medical Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Equity

Get a 7-Day Free Trial

0.02

0.04

0.08

1.09

-2.09

Allegra Medical Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.34	1.09	2.22	-2.09	-0.90

Competitive Comparison of Allegra Medical Technologies's Debt-to-Equity

For the Medical Devices subindustry, Allegra Medical Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Allegra Medical Technologies's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allegra Medical Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Allegra Medical Technologies's Debt-to-Equity falls into.

Allegra Medical Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Allegra Medical Technologies's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.45	+	2.678)	/	-1.499
	=	-2.09

Allegra Medical Technologies's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.454	+	0)	/	-1.613
	=	-0.90

Allegra Medical Technologies (ASX:AMT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Allegra Medical Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Allegra Medical Technologies (ASX:AMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066

Website

https://www.allegraorthopaedics.com

Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.